Invitrogen Trademark Details
Word Mark | Invitrogen |
---|---|
Status | Alive Registered 700 — Registered |
Current Owner
Serial Number | 77880998 |
---|---|
Registration Number | 4060554 |
Status Date | Tuesday, November 22, 2011 |
Filing Date | Tuesday, November 22, 2011 |
Registration Date | Tuesday, November 22, 2011 |
Attorney | Phil Makrogiannis |
Correspondent
Phil Makrogiannis
Life Technologies Corporation
5791 Van Allen Way
Carlsbad CA 92008
Life Technologies Corporation
5791 Van Allen Way
Carlsbad CA 92008
Case File Statements
Indication of Colors | Color is not claimed as a feature of the mark. |
---|---|
Description of Mark | The mark consists of a stylized DNA strand or "double helix" on a shaded circular background with a shaded circle above it followed by the word "INVITROGEN" in lowercase letters. |
Goods & Services | Reagents and kits comprised of reagents for scientific or medical research use; diagnostic reagents and kits comprised of diagnostic reagents for scientific or medical research use; diagnostic reagents for clinical or medical laboratory use; cellular pathway exploration tools, namely, enzyme-linked immunosorbent assay (ELISA), kinase activity assays, protein arrays, recombinant proteins and antibodies for analysis of multiple proteins and pathways for research purposes; key human, mouse and rat markers and antibodies conjugated to other proteins, namely, cytokines and chemokines for use in flow cytometry; cell and tissue culture media for non-medical use, cell/tissue culture growth supplements in the nature of biochemicals, reagents for use in cell/tissue cultures, and cells, all for use in scientific, laboratory, and medical research; In vitro ADME cell products, namely, fresh and cryopreserved hepatocytes and liver subcellular fractions, and transporters derived from a variety of species, including human, non-human primate, dog, rat and mouse, all for scientific, laboratory or medical research; Magnetic particle-based biomedical separation systems comprising magnetizable polymer beads, the attached antibody and the magnetic particle concentrator for separating a specific selected cell population from a larger, more complex cell population. Biological and biochemical preparations, namely, reagents and kits consisting of proteins, PCR fragments, cDNA libraries, vectors, enzymes, molecules, clones, genes, cell, recombination proteins and sites, restriction enzymes, primers, plasmids, and reagents all for scientific medical research, or research use; Microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for medical laboratory use; full line of kits consisting primarily of one or more of the following, namely, protein arrays, nucleic acids, hormones, purification supports, resins, cells, gels, probes, buffers, stains and associated reagents and devices for the expression, amplification, purification and analysis of biological samples for scientific or medical research use; fluorescent chemicals for use in scientific research; electrophoresis gel and chromatography chemicals, buffers, and solutions for scientific research; research and diagnostic biochemical and biological reagents, other than for medical or veterinary purposes, for agricultural, ecological, DNA typing, food processing and research use; reagents and assays used for detection and quantitation of DNA, RNA, protein or other analytes in solution, sold individually or in kits for research use; chemical reagents for non-medical purposes for the detection of pathogens and/or toxins in environmental samples; synthetic DNA for use in biotechnology; synthetic DNA and molecules used as DNA molecular weight standards in biotechnology fields; nucleotide arrays for scientific research; biochemical reagents for scientific research; buffers for use in analytical chemistry all for scientific and medical research use; chemicals, namely, reagents containing ligands, effector molecules and antibodies for scientific or medical research use; antibody-conjugated micro-beads and antibody-conjugated microspheres all for scientific and medical research use and for activation of immune system cells; fluorescent chemical dyes for clinical or medical laboratory use, namely, for measurement of pH in medical laboratories |
Goods & Services | Microbiological culture media, animal blood sera, mammalian and insect cells, mammalian and insect cell culture media and cell culture reagents, all for medical diagnostic use; diagnostic biochemical and biological reagents for use in detection or treatment for medical purposes; chemical reagents for the detection of pathogens and/or toxins in veterinary samples; pharmaceuticals preparations and compositions for therapeutic use, namely, for expanding, selecting and deleting cells of the immune systems; preparations and compositions for therapeutic use, namely, for activating cells of the immune systems; pharmaceutical preparations for use in the treatment of cancer, infectious diseases and immunodeficiencies; antibody-conjugated beads, antibody-conjugated micro-beads and antibody-conjugated microspheres for promoting a therapeutic effect on the body; chemical reagents for medical purposes |
Goods & Services | Computer software used for the collection, organization, analysis, integration and communication of scientific data; computer software used to operate laboratory instruments; laboratory instruments, namely, nucleic acid sequencers and synthesizers, genetic analyzers, thermal cyclers, cytometers, protein and peptide synthesizers, mass spectrometers and chromatographs, laboratory instruments for preparation of nucleic acid samples, laboratory robots; laboratory supplies, namely, racks, vials, caps, septa, needles, bottles, flasks, filters, tubes, and seals, plastic tray covers, micro plates, pipette tips, reagent reservoirs, optical heat field covers, plastic cards, and plastic capillary arrays; all for scientific and research use and diagnostics use; computer software for the construction of recombinant DNA molecules in the fields of molecular biology and genetics, building of functional or restriction maps, describing recombinant molecules, and obtaining the exact nucleotide sequences of recombinant DNA molecules; and computer software for use in database management in the fields of molecular biology and genetics that may be downloaded from a global computer network and computer software for use in database management in the fields of molecular biology and genetics; laboratory instruments, namely, magnetic particle concentrator to be used with magnetic particle-based biomedical separations; apparatus for protein and nucleic acid electrophoresis. Optical filters for wavelengths of light; detectors and/or analyzers, and components thereof, of proteins, nucleic acids, cellular metabolites, carbohydrates, viruses, bacteria and eukaryotic cells not for medical diagnostic use; laboratory instrument for performing automated washing, dispensing, hybridization, and imaging of chip based sequence specific oligonucleotides; fluorometer or spectrophotometer used for detection and quantitation of DNA, RNA, protein or other analytes in solution with detachable power cord; detachable Universal Serial Bus (USB) data cord; scientific apparatus, namely, assay tubes; software for analysis or results, all for use with a fluorometer or spectrophotometer; laboratory instrument for the detection of pathogens and/or toxins in a sample; laboratory equipment, namely, apparatus in the nature of biochips for identification, detection of presence of biological or chemicals in a sample and determination of physical or chemical properties of a sample; synthesizers for making polymer arrays and replacement parts therefor, and hybridization stations for making fluidic and microfluidic devices |
Goods & Services | Providing an on-line computer database featuring information in the field of scientific and medical research; consultation and research in the fields of science, technology, medicine and health, namely, nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; computer services, namely, providing temporary use of on-line non-downloadable software for accessing and analyzing information in the field of science, technology, medicine, health and public policy; medical, research and laboratory diagnostic services in the field of nucleic acid sequencing, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; product development for others; laboratory services, namely, nucleic acid sequencing, synthesis and analysis, analysis and synthesis of oligonucleotides and other molecules for others for use in life science research and biotechnology research; installation, maintenance and repair of computer software for scientific, research, medical, and diagnostic use; nucleic acid analysis; genetic research, namely, gene discovery; genetic disease research, genomics and gene expression research and development; pharmacokinetic research services; proteomics research services; gene identification, gene cloning, gene expression, gene mapping, electrophoresis, protein purification and analysis, and protein interaction detection, all for scientific and medical research purposes; medical and scientific research; medical and scientific research for the development and commercialization of cell-based therapeutic immune system stimulators and enhancers to treat cancer and infectious diseases; technical research and consultation services related thereto in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices; technical consultation services in the fields of development of pharmaceutical preparations and medicines, biological sciences, immunotherapy, and troubleshooting in the nature of diagnosing problems with medical devices; development of new products in the fields of pharmaceuticals, medicine, biological sciences, immunotherapy, and medical devices for others; medical laboratory services; research and development for new immunotherapy products for others; biopharmaceutical research and development; scientific research services; medical laboratory testing and diagnostic services for others in the fields of science and research related thereto; scientific research, namely, developing customized microbiological, mammalian, and insect culture media, media formulations, and cell culture reagents, and evaluating culture media for others; contract laboratory services, namely, drug-drug interaction studies, drug metabolism studies and hepatotoxicity studies, focused primarily on enzyme induction and inhibition, reaction phenotyping, metabolite stability and profiling, and P-gp assays and consulting services related thereto |
Pseudo Mark | In Vitro Gene |
Classifications
International Class Codes |
001
|
---|---|
U.S. Class Codes | 001, 005, 006, 010, 026, 046 |
Status | 6 — Active |
Status Date | Tuesday, December 1, 2009 |
First Use Anywhere | Saturday, September 4, 2004 |
First Use In Commerce | Saturday, September 4, 2004 |
Primary Code | 001 |
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Tuesday, December 1, 2009 |
First Use Anywhere | Saturday, September 4, 2004 |
First Use In Commerce | Saturday, September 4, 2004 |
Primary Code | 005 |
International Class Codes |
009
|
---|---|
U.S. Class Codes | 021, 023, 026, 036, 038 |
Status | 6 — Active |
Status Date | Tuesday, December 1, 2009 |
First Use Anywhere | Saturday, September 4, 2004 |
First Use In Commerce | Saturday, September 4, 2004 |
Primary Code | 009 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Tuesday, December 1, 2009 |
First Use Anywhere | Saturday, September 4, 2004 |
First Use In Commerce | Saturday, September 4, 2004 |
Primary Code | 042 |
Trademark Timeline
-
Sep 04 2004First use anywhere for the mark
-
Sep 04 2004First use in commerce for the mark
-
Sep 04 2004First use anywhere for the mark
-
Sep 04 2004First use in commerce for the mark
-
Sep 04 2004First use anywhere for the mark
-
Sep 04 2004First use in commerce for the mark
-
Sep 04 2004First use anywhere for the mark
-
Sep 04 2004First use in commerce for the mark
-
Nov 25 2009Trademark application filed with USPTO
-
Nov 28 2009New Application Entered In Tram
-
Dec 01 2009New Application Office Supplied Data Entered In Tram
-
Dec 02 2009Notice of Design Search Code and Pseudo Mark Mailed
-
Jan 19 2010Assigned To Examiner
-
Jan 21 2010Notification of Non-Final Action E-Mailed
-
Jan 21 2010Non-Final Action E-Mailed
-
Jan 21 2010Non-Final Action Written
-
Jul 21 2010Correspondence Received In Law Office
-
Jul 21 2010Teas Response To Office Action Received
-
Jul 22 2010Teas/email Correspondence Entered
-
Aug 04 2010Notification of Non-Final Action E-Mailed
-
Aug 04 2010Non-Final Action E-Mailed
-
Aug 04 2010Non-Final Action Written
-
Sep 16 2010Teas/email Correspondence Entered
-
Sep 16 2010Correspondence Received In Law Office
-
Sep 16 2010Teas Response To Office Action Received
-
Sep 17 2010Approved For Pub - Principal Register
-
Sep 25 2010Law Office Publication Review Completed
-
Sep 25 2010Assigned To Lie
-
Nov 02 2010Official Gazette Publication Confirmation E-Mailed
-
Nov 02 2010Published For Opposition
-
Dec 28 2010Noa E-Mailed - Sou Required From Applicant
-
Feb 01 2011Teas Change of Correspondence Received
-
Jun 27 2011Extension 1 Filed
-
Jun 27 2011Teas Extension Received
-
Jun 29 2011Extension 1 Granted
-
Jun 29 2011Case Assigned To Intent To Use Paralegal
-
Jun 30 2011Notice of Approval of Extension Request E-Mailed
-
Aug 02 2011Attorney Revoked And/or Appointed
-
Aug 02 2011Teas Revoke/appoint Attorney Received
-
Oct 14 2011Extension 2 Filed
-
Oct 14 2011Teas Statement of Use Received
-
Oct 14 2011Teas Extension Received
-
Oct 17 2011Statement of Use Processing Complete
-
Oct 17 2011Use Amendment Filed
-
Oct 17 2011Extension 2 Granted
-
Oct 18 2011Law Office Registration Review Completed
-
Oct 18 2011Allowed Principal Register - Sou Accepted
-
Oct 18 2011Notice of Approval of Extension Request E-Mailed
-
Oct 19 2011Notice of Acceptance of Statement of Use E-Mailed
-
Nov 22 2011Registered-Principal Register
-
Nov 22 2011Trademark officially registered with the USPTO
-
Jul 23 2014Attorney Revoked And/or Appointed
-
Jul 23 2014Teas Revoke/appoint Attorney Received